Early 2-Factor Transcription Factors Associated with Progression and Recurrence in Bevacizumab-Responsive Subtypes of Glioblastoma.
Simple Summary: This study has provided new insights into the role of E2F transcription factors, a group of proteins, in glioblastoma (GBM), a type of brain cancer. These proteins play a part in various processes that can lead to cell death, growth, and the formation of new blood vessels, all of whi...
| Published in: | Cancers Vol. 16; no. 14; pp. 2536 - 2556 |
|---|---|
| Main Author: | |
| Format: | equations & formulas research tables/charts Journal Article |
| Published: |
MDPI
Jul2024
|
| Online Access: | View this record in EBSCOhost |